The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.80
Bid: 0.00
Ask: 60.00
Change: 0.00 (0.00%)
Spread: 23.40 (63.934%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 36.80
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Billington faces headwinds; Immotion plans spin-off

Tue, 26th Apr 2022 18:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Immotion Group PLC - Manchester, England-based virtual reality entertainment company - Revenue for 2021 rises to GBP9.4 million from GBP2.8 million in 2020, with pretax loss narrowing to GBP2.0 million from GBP4.8 million. Says second half of year was one of "recovery and progress", particularly for Location Based Entertainment business, at a "much faster rate" than anticipated. "This, particularly in the United States, boosted our confidence in the potential of this part of our business as illustrated by very strong revenue and contribution growth to match," it says. This made it reconsider strategy for other two businesses, HBE and Uvisan, and concludes it needs to focus resources on LBE which has a strong pipeline. "We therefore intend to spin out HBE and Uvisan in the short term to enable us to be fully focused on LBE as we are confident that this compelling business model is highly scalable and can drive superior shareholder returns," it says.

----------

Billington Holdings PLC - Barnsley, England-based construction company - Revenue for 2021 rises 25% to GBP82.7 million from GBP66.0 million in 2020, but pretax profit drops 88% to GBP179,000 from GBP1.7 million. Says activity levels improved following the peak of the pandemic shutdowns experienced in 2020 and firm remained profitable in "challenging" market conditions. "2021 was a year of partial recovery for our markets as the worst effects of the Covid-19 pandemic abated. However, the group continued to face challenges from the continuing impact of the Covid-19 pandemic, raw material price increases, together with supply constraints for certain materials and labour," says Chief Executive Mark Smith. Dividend cut to 3.00 pence from 4.25p.

----------

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Revenue in 2021 amounts to USD17.4 million, up from USD11.8 million in 2020. Swings to pretax loss of USD59.0 million from profit of USD19.0 million in 2020, largely due to USD73.7 million share of net loss of associates accounted for using the equity method. Consolidated cash and cash equivalents stand at USD465.7 million at the end of December, easing to USD413.2 million at end of March, 2022. Spend largely attributed to the successful progression of wholly owned programs into more advanced stages of development. "Based on the strong foundation we have built to support PureTech's future growth, our Board and senior leadership team have been considering various approaches to drive additional value for our shareholders, including reviewing a capital allocation strategy that balances investment in the continued growth of our business with potential returns of capital to shareholders," says Founder & Chief Executive Officer Daphne Zohar.

----------

Focusrite PLC - High Wycombe, Buckinghamshire-based music and audio products company - Revenue for half-year to February 28 falls to GBP92.9 million from GBP95.3 million a year before. While revenue declines year-on-year, it remains well above pre-pandemic levels of GBP49.9 million. Pretax profit declines to GBP16.5 million from GBP23.6 million. "Demand for the group's portfolio of products has remained strong, and the group's overall performance in the half year was in line with our expectations and remains on track for the full year. As anticipated, demand and sales volumes for home creation solutions has tapered off from the unprecedented high levels during the peak of lockdown but remain materially ahead of pre pandemic levels," it says. Notes short-term downward pressure on gross margin from shortage of electronic components and high freight costs. Says outlook for industry remains positive and firm is on track to meet expectations for the full year. Interim dividend for period rises to 1.85p from 1.5p.

----------

Gaming Realms PLC - London-based developer and licensor of mobile focused gaming content - Revenue rises 29% to GBP14.7 million in 2021 from GBP11.4 million in 2020. Swings to pretax profit of GBP957,716 from loss of GBP1.6 million the year before. Says results "reflect the continued delivery of the core strategy of scaling the licensing business." Adds that momentum has continued in 2022, with Gaming Realms focusing on regulated markets and North America in particular. "The company has made an excellent start to the current year, with licensing revenues increasing by 43% year-on-year for the first quarter of 2022, and unique players increasing by 39% to over 1.5 million in the same period. This strong performance in the first quarter, combined with new markets and partners coming on stream, leads your board to believe the company will continue to grow significantly following its proven successful strategy," it says.

----------

Dillistone Group PLC - Basingstoke, England-based software and services provider that enables recruitment firms to manage their selection process - Says performance in 2021 was ahead of expectations, even as revenue falls to GBP5.6 million from GBP6.3 million, though pretax loss slims to GBP298,000 from GBP914,000. Firm reduces administrative expenses to GBP5.1 million from GBP6.6 million. "In my interim statement I highlighted that in our business, where a large part of our revenue is contracted annually in advance, the impact of Covid would be felt throughout the remainder of 2021. This proved to be the case, however we saw an uplift in orders in Q4 2021 to pre-pandemic levels," firm says. Says the current year has started well following a "strong finish" in 2021. Incoming orders in the first quarter of 2022 are up by 41%, and company says it is trading in line with expectations and does not expect to raise additional funds.

Separately, Dillistone says Chief Financial Officer Joanne Curd, who was appointed in 2021 on a part time basis, is leaving and will be replaced by Financial Controller Ian Mackin as interim finance director on a full-time basis from June 16.

----------

Warpaint London PLC - Buckinghamshire-based cosmetics maker - Revenue for 2021 rises to GBP50.0 million from GBP40.3 million in 2020, with firm swinging to pretax profit of GBP3.7 million from loss of GBP1.1 million the year before. "In 2021 we enjoyed a return to growth, with sales and profits exceeding those achieved in 2019, the last full period before the pandemic struck. During the year we focused on increasing our presence in larger retailers globally, through expanding existing relationships and developing new ones," firm says. Total dividend for year lifted to 6.0p from 5.8p in 2020. On start to 2022, firm says: "In the first quarter of 2022 we have enjoyed further profitable growth as we focus on supplying additional retailers and growing sales through our existing customers, taking more warehouse space and adding further stores."

----------

Futura Medical PLC - Guildford, England-based pharmaceutical firm - Pretax loss in 2021 widens to GBP5.9 million from GBP2.9 million in 2020, with no revenue generated in either year. "2021 has been a year of transformational progress and momentum for Futura as the Company achieved major milestones in terms of first regulatory approval for our lead product, MED3000, as an approved erectile dysfunction treatment and completion of a number of commercial MED3000 licensing deals as we continue to build a global distribution platform," it says. Adds that current cash runway extends beyond initial MED3000 launches expected over the next year and expected US regulatory approval in 2023, assuming no contributions from milestone payments or other revenue.

----------

Afentra PLC - upstream operator in Africa with carried interest in Odewayne block onshore southwestern Somaliland - Pretax loss for 2021 widens to USD5.0 million from USD1.9 million in 2020. No revenue recorded in either year. Widened loss follows increase in total administrative expenses. "It has been an active period for your company and we expect momentum to accelerate through 2022 as we strive to deliver our first value accretive transaction for our shareholders," firm says. Adds it remains debt free and fully carried for Odewayne operations.

----------

Light Science Technologies Holdings PLC - environment agriculture and technology and contract electronics manufacturing company - Reports revenue of GBP7.4 million for financial year to November 30, up from GBP6.9 million the year before, but firm swings to pretax loss of GBP2.3 million from profit of GBP147,995. Firm notes loss reflects cost of the AIM admission process and investment in CEA division. "With the large part of this financial year being pre-IPO, the main focus for Light Science Technologies was to develop its new market CEA products, IP collateral, and build its brand and a robust sales pipeline," it says. Notes headwinds such as Ukraine, Brexit, high energy costs and global electronic component shortages.

----------

ASA International Group PLC - Weybridge, Surrey-based microfinance lender - Total operating income for 2021 USD120.3 million, up from USD84.9 million in 2020. Pretax profit multiples to USD25.7 million from USD2.6 million. "I am particularly pleased that all but two of our major operating subsidiaries recovered to or exceeded pre-Covid operating and financial performance in 2021. Despite the ongoing challenges we face in India and Myanmar, the performance of most of our other operating countries, including, particularly, Ghana, Pakistan and Tanzania, was excellent in terms of portfolio quality, growth and profitability," says Chief Executive Dirk Brouwer. Company expects operating and financial performance should "substantially" improve in 2022.

----------

United Oil & Gas PLC - London-based oil and gas company with projects in Egypt, Italy and the UK - Revenue for 2021 jumps to USD19.2 million from USD9.1 million in 2020, with pretax profit surging to USD5.9 million from USD796,181. Group working interest 2021 production averaged 2,327 barrels of oil equivalent per day, up from 2,195 boepd in 2020. Realised oil price jumps to USD68.9 per barrel from USD37.8. Group working interest production in Egypt for 2022 is forecast to average between 1,500 and 1,650 boepd net.

----------

Corero Network Security PLC - Buckinghamshire, England-based distributed denial of service cyber defense - Revenue in 2021 rises to USD20.9 million from USD16.8 million in 2020, and firm swings to maiden pretax profit of USD1.4 million from loss of USD4.0 million. Gross margins improve to 85% from 77%. "The strong performance reflects the successful implementation of our growth strategy, with the group delivering continued sales momentum across our operational footprint," company says.

----------

Midatech Pharma PLC - Cardiff-based drug delivery technology company - Pretax loss for 2021 totals GBP6.1 million, narrowed from GBP23.5 million in 2020. This is on revenue that rises to GBP578,000 from GBP180,000. Takes no impairment in the year, versus charge of GBP12.4 million in 2020. "The directors are evaluating a number of near-term funding options potentially available to the group, including fundraising and the partnering of assets and technologies of the company," it says.

----------

Arrow Exploration Corp - Calgary, Canada-based oil and gas company - Total natural gas and crude oil revenue for 2021 rises to USD6.5 million from USD5.3 million the year before, with firm turning to net income of USD5.7 million from a loss of USD32.2 million. The company's fourth quarter average corporate production was 712 barrels of oil equivalent per day, an increase of 137 barrels a day compared to the third quarter. "The increase in production quarter-over-quarter was largely attributable to the Canadian operation following the tie-in of the West Pepper well in Alberta, Canada which was brought into production in December 2021," it says.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
10 Apr 2024 10:49

Futura Medical hails results as erectile dysfunction drug drives sales

(Alliance News) - Futura Medical PLC on Wednesday celebrated its "first set out meaningful revenues" in 2023, as sales for its erectile dysfunction treatment climbed.

Read more
3 Apr 2024 12:58

UK earnings, trading statements calendar - next 7 days

Thursday 4 April 
LungLife AI IncFull Year Results
Friday 5 April 
no events scheduled 
Monday 8 April 
Bango PLCFull Year Results
Ferrexpo PLCTrading Statement
Globaltrans Investment PLCFull Year Results
Tuesday 9 April 
Alliance Pharma PLCFull Year Results
CMC Markets PLCTrading Statement
hVIVO PLCFull Year Results
Imperial Brands PLCTrading Statement
JTC PLCFull Year Results
S&U PLCFull Year Results
Ultimate Products PLCHalf Year Results
Wednesday 10 April 
Churchill China PLCFull Year Results
Futura Medical PLCFull Year Results
M&C Saatchi PLCFull Year Results
Marshalls PLCFull Year Results
Tesco PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
14 Feb 2024 09:24

IN BRIEF: Futura Medical's Eroxon to soon be available on prescription

Futura Medical PLC - Guildford, England-based pharmaceutical company focused on sexual health products - Confirms that lead product Eroxon will from March 1 be available on prescription in England and Wales for the treatment of erectile dysfunction. Eroxon is a gel-based treatment designed to help the user obtain an erection, and serves as an alternative for people who are unwilling or unable to use medications like Viagra. Eroxon has also been available without a prescription in UK pharmacies since March last year.

Read more
6 Feb 2024 17:04

LONDON MARKET CLOSE: BP and Prudential help snap FTSE losing streak

(Alliance News) - Stock prices in London pushed higher on Tuesday, with the FTSE 100 registering its first rise in four trading days, with oil major BP the star performer.

Read more
6 Feb 2024 12:24

Futura Medical shares surge after "transformational year"

(Alliance News) - Futura Medical PLC on Tuesday reported its first revenues in 2023, thanks to the successful global roll-out of Eroxon.

Read more
6 Feb 2024 10:08

Futura has 'transformational year' in 2023

(Sharecast News) - Consumer healthcare company Futura said on Tuesday that 2023 had been a "transformational year", with the group generating its first meaningful revenues and laying the foundations for "significant growth acceleration".

Read more
15 Jan 2024 14:59

Futura Medical extends agreement with Cooper Consumer Health

(Sharecast News) - Sexual health product developer Futura Medical announced an extension of its exclusive licensing agreement with Cooper Consumer Health on Monday.

Read more
15 Jan 2024 08:35

Futura Medical extends licensing deal for erectile dysfunction gel

(Alliance News) - Futura Medical PLC on Monday said that it has extended its exclusive licensing agreement with Cooper Consumer Health Group, a European self-care organisation, to January 2029.

Read more
7 Nov 2023 17:47

TRADING: Zambeef sees profit above market views; Luceco trades in line

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
25 Oct 2023 12:21

Futura Medical gets Mexico marketing authorisation for Eroxon gel

(Alliance News) - Futura Medical PLC on Wednesday said the Mexican Secretariat of Health has granted over the counter sale marketing authorisation for its erectile dysfunction topical gel formulation Eroxon.

Read more
19 Oct 2023 14:17

IN BRIEF: Futura Medical launches erectile dysfunction gel in UAE

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says that it has launched Exoron in the United Arab Emirates. Exoron, or MED3000, is a topical gel used to treat erectile dysfunction. It uses Futura's proprietary technology, DermaSys. The product is now available for purchase online through the BinSina Pharmacy in the UAE, the first market in the Middle East to stock the product.

Read more
2 Oct 2023 14:22

Futura Medical wis European patent for erectile dysfunction gel

(Sharecast News) - Sexual health specialist Futura Medical announced the successful acquisition of an EU patent for its MED3000 topical erectile dysfunction product on Monday.

Read more
2 Oct 2023 12:13

IN BRIEF: Futura Medical granted European patent for ED treatment

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Receives European patent for erectile dysfunction treatment, MED3000, until 2040. Continues to pursue patent applications to provide wider patent protection. Chief Executive Officer James Barder says: "The allowance of this patent application further cements the intellectual property of MED3000, as we support our distributors' roll out of our fast acting topically applied gel for the treatment of erectile dysfunction available without a doctor's prescription across the world."

Read more
18 Sep 2023 11:28

TRADING UPDATES: Elixirr record half-year revenue; Bango profit down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
11 Sep 2023 15:44

UK earnings, trading statements calendar - next 7 days

Tuesday 12 September 
Associated British Foods PLCTrading Statement
Cornerstone FS PLCHalf Year Results
Creo Medical Group PLCHalf Year Results
Digital 9 Infrastructure PLCHalf Year Results
Dowlais Group PLCHalf Year Results
Eleco PLCHalf Year Results
Equals Group PLCHalf Year Results
Feedback PLCFull Year Results
Fevertree Drinks PLCHalf Year Results
Gym Group PLCHalf Year Results
Harworth Group PLCHalf Year Results
hVIVO PLCHalf Year Results
IQE PLCHalf Year Results
Itaconix PLCHalf Year Results
JTC PLCHalf Year Results
Keywords Studios PLCHalf Year Results
Mattioli Woods PLCFull Year Results
Ocean Harvest Technology Group PLCHalf Year Results
Property Franchise Group PLCHalf Year Results
Regional REIT LtdHalf Year Results
Smart Metering Systems PLCHalf Year Results
Wednesday 13 September 
abrdn Smaller Companies Income Trust PLCHalf Year Results
Argentex Group PLCHalf Year Results
Brave Bison Group PLCHalf Year Results
Burford Capital LtdHalf Year Results
CAB Payments Holdings PLCHalf Year Results
Central Asia Metals PLCHalf Year Results
Frontier Developments PLCFull Year Results
Made Tech Group PLCFull Year Results
On The Beach Group PLCTrading Statement
Pan African Resources PLCFull Year Results
Pharos Energy PLCHalf Year Results
Ricardo PLCFull Year Results
Star Energy Group PLCHalf Year Results
Tullow Oil PLCHalf Year Results
Thursday 14 September 
Arecor Therapeutics PLCHalf Year Results
Brooks Macdonald Group PLCFull Year Results
Capricorn Energy PLCHalf Year Results
Checkit PLCHalf Year Results
Churchill China PLCHalf Year Results
Foresight Solar Fund LtdHalf Year Results
Glenveagh Properties PLCHalf Year Results
IG Group Holdings PLCTrading Statement
Keystone Law Group PLCHalf Year Results
Kier Group PLCFull Year Results
M&C Saatchi PLCHalf Year Results
MJ Gleeson PLCFull Year Results
Oakley Capital Investments LtdHalf Year Results
Renishaw PLCFull Year Results
Spire Healthcare Group PLCHalf Year Results
THG PLCHalf Year Results
Trainline PLCTrading Statement
Uniphar PLCHalf Year Results
Friday 15 September 
Petra Diamonds LtdFull Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Monday 18 September 
Artisanal Spirits Co PLCHalf Year Results
City of London Investment Group PLCFull Year Results
Downing Renewables & Infrastructure Trust PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Futura Medical PLCHalf Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Phoenix Group Holdings PLCHalf Year Results
S4 Capital PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.